Bionik Laboratories announced today that it appointed a new chief executive officer and president, as well as a chief financial officer.
The company named Richard Russo, who previously served as CFO, as its new president and CEO. It selected Dan Gonsalves to assume the role as EVP and CFO. Gonsalves previously held the position of corporate controller.
Boston-based Bionik Labs made both appointments effective immediately.
The company said its new executive appointments will implement its recently announced strategic growth plan. This plan includes a roadmap of branded outpatient care centers and commercial expansion to new global markets. The company aims to amplify data collection and analysis across its devices, too.
“Bioniks’ new strategic plan is designed to bring neuro-recovery care centers nationwide to showcase and provide additional accessibility to our technology and solutions through a patient care model that goes beyond the boundaries o…